Combination therapy of disseminated Fusarium oxysporum infection with terbinafine and amphotericin B

Ann Hematol. 2004 Jun;83(6):394-7. doi: 10.1007/s00277-003-0795-x. Epub 2003 Nov 27.

Abstract

A case of disseminated infection with Fusarium oxysporum following chemotherapy of acute myelogenous leukemia is reported. Antifungal treatment was successful with a 13-day course of oral terbinafine 250 mg t.i.d. in combination with amphotericin B deoxycholate 1.0-1.5 mg/kg qd and subsequently intravenous liposomal amphotericin B 5 mg/kg qd. Preceding monotherapy with amphotericin B deoxycholate 1.0-1.5 mg/kg qd had not stopped the progression of infection. The combination therapy described here represents a novel approach to the treatment of Fusarium spp. in the immunocompromised host in whom Fusarium spp. are known to cause disseminated infection with high mortality.

Publication types

  • Case Reports

MeSH terms

  • Amphotericin B / administration & dosage*
  • Antifungal Agents / administration & dosage*
  • Dermatomycoses / blood
  • Dermatomycoses / drug therapy*
  • Dermatomycoses / immunology
  • Dermatomycoses / pathology
  • Drug Therapy, Combination
  • Fusarium*
  • Humans
  • Immunocompromised Host
  • Leukemia, Myeloid, Acute / blood
  • Leukemia, Myeloid, Acute / microbiology
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Naphthalenes / administration & dosage*
  • Naphthalenes / blood
  • Neutropenia / drug therapy
  • Neutropenia / pathology
  • Terbinafine
  • Treatment Outcome

Substances

  • Antifungal Agents
  • Naphthalenes
  • Amphotericin B
  • Terbinafine